We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Wilmcote Holdings Plc | LSE:WCH | London | Ordinary Share | JE00BZBYC658 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.00 | 2.00 | 4.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMWCH
RNS Number : 4624Q
Wilmcote Holdings PLC
21 October 2019
21 October 2019
This announcement contains inside information
Wilmcote Holdings plc
Directorate change
Wilmcote Holdings plc ('Wilmcote' or the 'Company') announces that further to the recent decision to conclude negotiations with Arclin Inc., it has been mutually agreed that Adrian Whitfield (CEO), Kevin Dangerfield (CFO) and John McAdam (Non-Executive Director) will step down from the Board and leave the Company with immediate effect.
The Board would like to thank Adrian, Kevin and John for bringing a number of exciting investment opportunities to Wilmcote and wish them well in their future endeavours.
The Board acknowledge that these changes will affect the Company's adherence to the QCA Code and will continue to consider the appropriate corporate governance arrangements for the Company, subject to its circumstances.
The Board continue to hold discussions with shareholders regarding the future of the Company and will release a further announcement in due course.
-ENDS-
Teneo (Financial PR)
Tel: +44 (0) 7703 330 269
Charles Armitstead
Numis Securities Limited (Nominated Adviser and Broker)
Tel: +44 (0) 20 7260 1000
Kevin Cruickshank
Jamie Loughborough
James Corsellis is Chairman of Wilmcote Holdings plc, which has its offices at 11 Buckingham Street, London, WC2N 6DF and has the LEI number 2138004EUUU11OVHZW75.
Notes to Editors
On 11 October 2019, the Company released the following announcement.
"Wilmcote Holdings plc ('Wilmcote' or the 'Company') announces that, further to its recent statements regarding a potential acquisition of Arclin Inc. ('Arclin'), the Company and Arclin have mutually agreed to conclude negotiations and, as such, discussions have ceased.
In line with the Company's mandate to pursue acquisition opportunities, Wilmcote has incurred material third party expenses in connection with this opportunity. The Company estimates it will have approximately GBP0.9 million in residual cash reserves following the settlement of negotiated transaction-related expenses, including associated VAT refunds.
Wilmcote intends to hold discussions with shareholders regarding the potential further capitalisation of the Company to fund future operating expenses and due diligence to continue to pursue acquisition opportunities in the specialty chemicals sector. A further announcement will be made following the conclusion of these discussions.
Wilmcote's ordinary shares will recommence trading with immediate effect."
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOABIBDGUDDBGCG
(END) Dow Jones Newswires
October 21, 2019 02:00 ET (06:00 GMT)
1 Year Wilmcote Chart |
1 Month Wilmcote Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions